Study of JNP-0101 in patients with overactive bladder

Trial Profile

Study of JNP-0101 in patients with overactive bladder

Planning
Phase of Trial: Phase II

Latest Information Update: 04 Aug 2016

At a glance

  • Drugs Oxybutynin (Primary)
  • Indications Overactive bladder
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 04 Aug 2016 Results published in the Media Release.
    • 11 Jan 2016 This trial is expected to begin in the second half of 2016, according to a Juniper Pharmaceuticals media release.
    • 20 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top